Skip to main content

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.780 UNCHANGED
Official Closing Price Updated: 4:10 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form DEFA14A
Source: SEC/Edgar
April 17, 2018
Form 8-K
Source: SEC/Edgar
April 15, 2018
Form CT ORDER
Source: SEC/Edgar
April 02, 2018
Form DEFA14A
Source: SEC/Edgar
April 01, 2018
Form 8-K
Source: SEC/Edgar
March 20, 2018
Form 8-K
Source: SEC/Edgar
March 05, 2018
Form DEF 14A
Source: SEC/Edgar
March 05, 2018
Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G/A
Source: SEC/Edgar
February 11, 2018
Form SC 13G
Source: SEC/Edgar
February 08, 2018
Form 8-K
Source: SEC/Edgar
January 30, 2018
Form SC 13G/A
Source: SEC/Edgar
January 24, 2018
Form 8-K
Source: SEC/Edgar
January 04, 2018
Form 8-K
Source: SEC/Edgar
November 30, 2017
Form 8-K
Source: SEC/Edgar
November 26, 2017
Form 8-K
Source: SEC/Edgar
November 12, 2017
Form 8-K
Source: SEC/Edgar
October 19, 2017
Form 8-K
Source: SEC/Edgar
October 18, 2017
Form DEFA14A
Source: SEC/Edgar
October 09, 2017
Form DEF 14A
Source: SEC/Edgar
August 31, 2017
Form DEF 14A
Source: SEC/Edgar
August 24, 2017
Form PRE 14A
Source: SEC/Edgar
August 09, 2017
Form 8-K
Source: SEC/Edgar
July 24, 2017
Form SC 13G/A
Source: SEC/Edgar
July 09, 2017
Form 8-K
Source: SEC/Edgar
April 17, 2017
Form 8-K
Source: SEC/Edgar
April 11, 2017
Form 8-K
Source: SEC/Edgar
April 11, 2017
Form DEFA14A
Source: SEC/Edgar
March 28, 2017
Form DEF 14A
Source: SEC/Edgar
March 15, 2017
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.